Proton Therapy denied as not FDA-approved for this use by Aetna?

Aetna's specific coverage criteria for proton therapy are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Aetna Denies Proton Therapy as Not FDA-Approved — and Why This Denial Has a Specific Weakness

A "not FDA-approved" denial for proton beam radiation therapy is one of the more legally vulnerable denial types for this treatment. Proton therapy equipment and delivery systems have received FDA clearance as radiation therapy devices. This denial likely reflects either a misapplication of the FDA-approval standard, confusion between FDA drug approval (not applicable to a radiation modality) and FDA device clearance, or a plan-specific policy position that uses "FDA approval" language to mean something narrower — such as approval for a specific indication rather than clearance of the modality itself.

You should request from Aetna, in writing, the precise basis for the "not FDA-approved" characterization — specifically, what approval or clearance Aetna contends is absent. This clarification is essential before you build your appeal, because the response strategy differs depending on whether Aetna is contesting device clearance, indication-specific approval, or something else entirely.

## Federal Appeal Rights

• Internal appeal (ACA §2719 / ERISA §503): You are entitled to a full-and-fair internal review. Request the complete clinical and regulatory basis for the denial, including any specific FDA approval Aetna contends is required.
• External review (ACA §2719): Independent external review is available for coverage denials based on medical judgment, which includes most "not approved" determinations. File within the window stated in your denial letter, generally within four months of the final internal denial.
• Expedited review: If your treatment is clinically urgent, request expedited processing.

## Documentation to Gather

• FDA device clearance documentation: Your radiation oncologist or the proton therapy center can provide documentation of the FDA clearance status of proton therapy equipment — this directly rebuts a clearance-based denial.
• Radiation oncologist's letter: Addressing the specific approval basis Aetna cited; explaining the regulatory pathway for radiation therapy devices versus drugs; and establishing that proton therapy is delivered using FDA-cleared equipment.
• Applicable guideline organization reference: Documentation that the relevant guideline body (e.g., NCCN, ASTRO) recognizes proton therapy as an accepted modality for your indication.
• Institutional utilization: Evidence that proton therapy is routinely offered at NCI-designated cancer centers and academic medical institutions.
• Plan policy language: A copy of Aetna's current clinical policy bulletin and your plan documents, to determine precisely what "FDA approval" standard is being applied.

## Criteria-Mapping Structure

Once you have Aetna's written explanation of the specific approval basis at issue, map your evidence to each element:

| Aetna's Stated Approval Requirement | Your Evidence | |---|---| | Device/modality clearance | FDA clearance documentation for proton equipment | | Indication-specific recognition | Guideline organization reference; prescriber letter | | Standard-of-care status | Institutional utilization; tumor board recommendation | | Policy definition of "approved" | Plan policy language; request clarification in writing |

Do not assume you understand what Aetna means by "not FDA-approved" without getting their written explanation — the specific regulatory claim they are making determines the right rebuttal evidence.